Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Balchem (BCPC)

Balchem Q4 2024 net sales rise 4.9% to $240.0 million; GAAP EPS $1.03

Positive Impact 3 of 5 earnings Written later

Balchem reported fourth quarter 2024 results on February 21, 2025, with net sales of $240.0 million, up 4.9% from the prior year quarter, and GAAP net earnings of $33.6 million, up 26.0%. For the full year, net sales were $953.7 million and GAAP earnings per share were $3.93, compared with $3.35 in 2023. The filing gives no new financial guidance.

Key points

  • Q4 2024 net sales $240.0 million, up $11.3 million or 4.9%
  • Q4 GAAP diluted EPS $1.03 vs. $0.82; adjusted EPS $1.13 vs. $0.95
  • Full-year 2024 GAAP net earnings $128.5 million, up 18.4%; adjusted EBITDA $250.3 million, up 8.4%
  • Full-year free cash flow $147.2 million; company paid down $119.6 million of debt

The filing

CompanyBalchem (BCPC)
Form8-K, current report
Filed with the SECFeb 21, 2025, 7:21 AM ET
Accession number0001628280-25-006975

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 21, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.